Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
2023 · Signal Transduction and Targeted Therapy · 266 citations
https://doi.org/10.1038/s41392-022-01235-0
B
Bin‐Yan Zhong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
99
Papers
1.9K
Citations
21
h-index
36
i10-index
Bin‐Yan Zhong is an academic researcher. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation. The author has an h-index of 21, co-authored 85 publications.
ORCID: 0000-0001-9716-1211Papers by this author
worksClinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional Oncology (ISMIO)
2021 · HepatoBiliary Surgery and Nutrition · 123 citations
https://doi.org/10.21037/hbsn-21-260
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study
2024 · EClinicalMedicine · 119 citations
https://doi.org/10.1016/j.eclinm.2024.102622
Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study
2023 · European Radiology · 75 citations
https://doi.org/10.1007/s00330-023-09754-2
Combination locoregional and systemic therapies in hepatocellular carcinoma
2025 · The Lancet. Gastroenterology & hepatology · 45 citations
https://doi.org/10.1016/s2468-1253(24)00247-4
Machine-learning analysis of contrast-enhanced computed tomography radiomics predicts patients with hepatocellular carcinoma who are unsuitable for initial transarterial chemoembolization monotherapy: A multicenter study
2021 · Translational Oncology · 40 citations
https://doi.org/10.1016/j.tranon.2021.101034
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat